Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Clinical trial NCT00942968 · COMPLETED
Trial details
- NCT number
- NCT00942968
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2012-03-01
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.